Sign in
AMRN Stock Price, Chart, Stats & News
Amarin Corporation plc
Save
Amarin Corporation plc (AMRN) does not currently pay a dividend.
304.04M
Market cap
–
Current P/E
500.00x
Forward P/E
AMRN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 65.74% |
Operating margin | -12.70% |
Pretax margin | -23.01% |
Net margin | -21.10% |
Effective tax rate | 8.28% |
ROA | -5.78% |
ROE | -8.36% |
D/E | 0.03x |
Interest coverage ratio | -23347.00x |
AMRN valuation
P/E | – |
P/S | 1.63x |
P/B | 13.09x |
P/CF | 902.37x |
P/FCF | 44.86x |
P/OCF | 902.37x |
PEG | -2.73x |
EV multiple | -25.61x |
About
Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's flagship product is VASCEPA, an omega-3 fatty acid formulation available by prescription only.
Similar securities
Based on sector and market capitalization
Report issue